Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Zeroing in on Xylazine

November 30, 2022
5:00 pm–6:00 pm ET

This 1 hour training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.

Register now

Virtual meeting

Via Zoom

Description

This training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss the physiologic effects of Xylazine, manifestations of Xylazine intoxication, overdose, communicable infections associated with Xylazine use, and wound care for persons injecting Xylazine.

Intended audience

Providers, nurses, counselors, and other non-clinical staff are welcome to attend.

Speakers

Raagini Jawa, MD, MPH

Dr. Jawa is an Assistant Professor and Clinician Investigator in the Department of General Internal Medicine at University of Pittsburgh Medical Center and a clinician investigator in the Center for Research on Health Care.  She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa’s research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions so as to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends on the Endovascular Infection Service at UPMC. 

Objectives

Following this training, participants will have the knowledge necessary to: 

  1. Describe the physiologic effects of xylazine. 
  2. Recognize manifestations of intoxication in persons using xylazine.
  3. Recall signs of xylazine overdose and appropriate response.
  4. Identify common skin and soft tissue infections associated with xylazine use.
  5. Describe practices to decrease risk of skin and soft tissue infections in persons using xylazine.
  6. Recall methods of wound care for persons injecting xylazine.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

Boston Medical Center grants 1.00 hours to all RNs who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston University School of Social Work which is authorized through the MA state board of Social Work to provide 1.00 CE Credit Hours.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2022 Boston Medical Center. All rights reserved. Site by Root802.